Cargando…

Neoadjuvant immunotherapy in primary and metastatic colorectal cancer

BACKGROUND: Colorectal cancer (CRC) is the second most common solid organ cancer. Traditional treatment is with surgery and chemotherapy. Immunotherapy has recently emerged as a neoadjuvant therapy that could change treatment strategy in both primary resectable and metastatic CRC. METHODS: A literat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanani, A, Veen, T, Søreide, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364874/
https://www.ncbi.nlm.nih.gov/pubmed/34694371
http://dx.doi.org/10.1093/bjs/znab342